#United Kingdom #Leo Cancer Care #Marie #Upright Radiotherapy #Crawley

Leo Cancer Care's Revolutionary Step in Radiotherapy

Leo Cancer Care has made headlines with its recent announcement regarding the Marie® upright radiotherapy system, which has received CE marking. This significant milestone not only paves the way for commercial deployment across Europe but also heralds a transformative shift in cancer treatment delivery.

A Paradigm Shift in Patient Care

For decades, patients undergoing radiotherapy have been confined to lying flat on their backs during treatment, a protocol that has influenced system designs and clinical practices. However, Mario® changes the game by allowing patients to receive treatment in an upright position. “This innovative approach puts the patient in the center of care, rethinking conventional radiotherapy design and delivery,” said Stephen Towe, CEO of Leo Cancer Care.

The implications of upright treatment delivery extend well beyond mere comfort. By facilitating treatments that cater to both existing and future therapeutic modalities, Marie® is an innovative platform poised to redefine cancer care.

Benefits and Flexibility

The benefits of consequently implementing Marie® are multi-faceted:

• - Natural Patient Experience: Upright treatment offers a more comfortable and instinctive treatment journey for patients.
• - Enhanced Treatment Delivery: The system supports advanced therapeutic methods, including online adaptive and arc therapy.
• - Broader Accessibility: Institutions with limitations in adopting traditional particle therapy solutions will find Marie® a viable alternative.
• - Future-Proofing: Its adaptability allows for supporting future advancements in radiotherapy, positioning it as a versatile treatment platform for years to come.

Leo Cancer Care has confirmed that the CE marking signifies that Marie® meets the highest European standards for safety, performance, and clinical readiness. This meticulous process involved extensive research, engineering efforts, and clinical collaborations with various partners in the radiation oncology sector.

Collaborative Efforts Swell

One notable collaborator is the Centre Léon Bérard, a French hospital dedicated to cancer care and research. They are set to expand their relationship with Leo Cancer Care post-CE approval by enhancing anatomical imaging techniques while utilizing Marie's upright CT capabilities.

Director General Dr. Sandro Rossi from the Centro Nazionale di Adroterapia Oncologica (CNAO) in Italy praised the new technology's integration into traditional workflows. “This partnership marks a pivotal transformation in our approach to treatment precision and patient care. The combination of innovative upright positioning technology and our specialized clinical expertise aims to advance oncological solutions,” he stated.

A New Era Awaits

Now that regulatory hurdles have been overcome, Leo Cancer Care is poised to work with leading cancer centers across Europe to integrate upright radiotherapy into their clinical practices. The company's vision of enhancing treatment precision while prioritizing the patient experience is on the verge of becoming a reality for many across the continent.

As European cancer centers begin installations, including the first at CNAO, the first patient treatments are expected to commence by the end of the year. With such advancements, we stand on the cusp of a new era in the fight against cancer, one where patient-centric approaches take center stage. The future of oncology might be just a step away, literally, as we embrace upright radiotherapy with the Marie® system.